Picton Mahoney Asset Management’s Zura Bio ZURA Stock Holding History

Picton Mahoney Asset Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$1.02M	–	602
2022 Q4	$1.02M	Hold	100,000	–	–	0.05%	366
2022 Q3	$1.01M	Hold	100,000	–	–	0.04%	428
2022 Q2	$995K	Hold	100,000	–	–	0.04%	524
2022 Q1	$991K	Hold	100,000	–	–	0.04%	547
2021 Q4	$988K	Buy	+100,000	New	+$987K	0.02%	570

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Picton Mahoney Asset Management's ZURA Position: Q1 2023 in Review

Picton Mahoney Asset Management sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 100,000 shares — an estimated $1.02M sold.

Picton Mahoney Asset Management first reported a position in ZURA in Q4 2021 and held it in 5 quarters. The position peaked at $1.02M in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Picton Mahoney Asset Management reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 100,000 Zura Bio shares in Q1 2023, an estimated $1.02M.
Picton Mahoney Asset Management first reported a position in Zura Bio in Q4 2021 and held it in 5 quarters.
Picton Mahoney Asset Management's Zura Bio position peaked at $1.02M in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2023, filed 8 May 2023.